Literature DB >> 17275423

An optimized analytical method of fluconazole in human plasma by high-performance liquid chromatography with ultraviolet detection and its application to a bioequivalence study.

Sung-Su Kim1, Ho-Taek Im, Il-Mo Kang, Hyun-Su Lee, Heon-Woo Lee, Sung-Hee Cho, Jong-Bin Kim, Kyung-Tae Lee.   

Abstract

A sensitive and accurate HPLC-UV method for the quantification of fluconazole (FLA) level in human plasma has been developed. The sample was prepared by one-step liquid-liquid extraction (LLE) of FLA from plasma using dichloromethane. Phenacetin was used as the internal standard. The chromatographic retention times of FLA and phenacetin were 4.6 and 8.3 min, respectively. The lower limit of quantitation (LLOQ) was 0.05 microg/mL, and no interferences were detected in the chromatograms. The devised HPLC-UV method was validated by evaluating its intra- and inter-day precisions and accuracies in a linear concentration range between 0.05 and 10.00 microg/mL. The devised method was successfully applied to a bioequivalence studies involving the oral administration of a single 150 mg FLA tablet and 3 x 50 mg FLA capsules in healthy Korean male volunteers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17275423     DOI: 10.1016/j.jchromb.2007.01.012

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  6 in total

1.  Multicenter comparison of the ISO standard 20776-1 and the serial 2-fold dilution procedures to dilute hydrophilic and hydrophobic antifungal agents for susceptibility testing.

Authors:  Alicia Gomez-Lopez; Maiken Cavling Arendrup; Cornelia Lass-Floerl; Juan-Luis Rodriguez-Tudela; Manuel Cuenca-Estrella
Journal:  J Clin Microbiol       Date:  2010-03-10       Impact factor: 5.948

2.  GFR may not accurately predict aspects of proximal tubule drug handling.

Authors:  T L Putt; Stephen B Duffull; J B W Schollum; R J Walker
Journal:  Eur J Clin Pharmacol       Date:  2014-08-20       Impact factor: 2.953

3.  Effect of Efflux Transporter Inhibition on the Distribution of Fluconazole in the Rat Brain.

Authors:  Wei Wang; Na Zheng; Jiatang Zhang; Xusheng Huang; Shengyuan Yu
Journal:  Neurochem Res       Date:  2017-03-24       Impact factor: 3.996

4.  Correlation of the in vitro antifungal drug susceptibility with the in vivo activity of fluconazole in a murine model of cerebral infection caused by Cryptococcus gattii.

Authors:  F E S Mendes; L V N Oliveira; E S Faria; D G Alvarenga; M R Pinto; C P Taborda; B M Soares; P S Cisalpino; D A Santos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-08-28       Impact factor: 3.267

5.  Comparison of fluconazole renal penetration levels in healthy and Candida albicans-infected Wistar rats.

Authors:  Francine Johansson Azeredo; Bibiana Verlindo de Araújo; Sandra Elisa Haas; Bruna Torres; Maiara Pigatto; Cristiane de Andrade; Teresa Dalla Costa
Journal:  Antimicrob Agents Chemother       Date:  2012-09-04       Impact factor: 5.191

6.  Pharmacokinetics and pharmacodynamics of fluconazole for cryptococcal meningoencephalitis: implications for antifungal therapy and in vitro susceptibility breakpoints.

Authors:  Ajay Sudan; Joanne Livermore; Susan J Howard; Zaid Al-Nakeeb; Andrew Sharp; Joanne Goodwin; Lea Gregson; Peter A Warn; Tim W Felton; John R Perfect; Thomas S Harrison; William W Hope
Journal:  Antimicrob Agents Chemother       Date:  2013-04-09       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.